Menu Search
Equities

WELL Health Technologies Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
W7V:FRA

WELL Health Technologies Corp

Actions
  • Price (EUR)2.43
  • Today's Change-0.008 / -0.33%
  • Shares traded600.00
  • 1 Year change-40.53%
  • Beta1.2178
Data delayed at least 15 minutes, as of Feb 06 2026 15:05 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

WELL Health Technologies Corp. is a Canada-based digital healthcare company. Its healthcare and digital platform includes front and back-office management software applications that help physicians. Its business units include Canadian Patient Services, WELL Health USA Patient and Provider Services, and SaaS and Technology Services. The Canadian Patient Services segment provides primary care and allied health clinic operations in Canada and specialty care and accredited diagnostic health services from WDC. The WELL Health USA Patient and Provider Services segment includes U.S. primary care telehealth operations from Circle Medical; U.S. primary care operations from WISP; specialized care gastroenterology anesthesia services, and specialized medical recruitment and staffing services. The SaaS and Technology Services segment includes aggregation of electronic medical records, billing and revenue cycle management solutions, digital applications, and cybersecurity operating segments.

  • Revenue in CAD (TTM)1.21bn
  • Net income in CAD-43.25m
  • Incorporated2010
  • Employees3.20k
  • Location
    WELL Health Technologies CorpSuite 550 - 375 Water StreetVANCOUVER V6B 5C6CanadaCAN
  • Phone+1 (604) 628-7266
  • Fax+1 (604) 628-7266
  • Websitehttps://www.well.company/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.